Iceland Genomics

deCODE genetics is the canonical leader in human genomics based in Reykjavik, Iceland—notably acquired by Amgen since 2012—and has pioneered large-scale population-based gene discovery that underpins much modern precision medicine. The company's unique access to comprehensive genealogical records and broad participation from the Icelandic public enables unparalleled insights into genetic risk factors for common complex diseases such as cancer and cardiovascular conditions. While not itself a therapeutic developer or manufacturer, its platform discoveries are widely used by pharma partners globally to guide drug development programs.